Anthony Neuger

<i>All-trans</i>-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients

Noweeda Mirza, Mayer Fishman, Ingo Fricke et al. · Cancer Research · 2006 · 557 citations · Full text

Medicine, Immunology, Pharmacology +16

Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer

Eric B. Haura, Tawee Tanvetyanon, Alberto Chiappori et al. · Journal of Clinical Oncology · 2010 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC

Pamela N. Münster, Douglas C. Marchion, Elona Biçaku et al. · Clinical Cancer Research · 2009 · 150 citations

Medicine, Oncology, Pharmacology +16

A phase I study of indoximod in patients with advanced malignancies

Hatem Soliman, Susan Minton, Hyo S. Han et al. · Oncotarget · 2016 · 144 citations · Full text

Medicine, Oncology, Pharmacology +6

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth

Melanie Mediavilla-Varela, Kimberly A. Luddy, David Noyes et al. · Cancer Biology & Therapy · 2013 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17